AQST
Aquestive Therapeutics, Inc. Common StockstockNASDAQ
aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.61 | 2026-11-06 | +8.31% | -0.228 |
| 1M | 4.67 | 2026-10-13 | -16.27% | 0.749 |
| 3M | 4.25 | 2026-08-13 | -8.00% | 0.688 |
| 6M | 4.13 | 2026-05-13 | -5.33% | 0.791 |
| 1Y | 5.30 | 2025-11-13 | -26.23% | 0.833 |
| 2Y | 4.83 | 2024-11-13 | -19.05% | — |
| 5Y | 6.29 | 2021-11-12 | -37.84% | 1.262 |
Aquestive Therapeutics, Inc. Common Stock (NASDAQ:AQST) stock price today is $3.91, and today's volume is 3,966,974. AQST is up 9.524% today. The 30 day average volume is 2.37M. AQST market cap is $491.44M with 125.69M shares outstanding.